RWJ-22108--a Novel Airway Tissue--selective Calcium Channel Blocker

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1993 Sep 1

PMID 8147270

Authors

J B Moore Jr

W C Miller

S Mockoviak

Affiliations

Soon will be listed here.

Abstract

RWJ-22108 is a novel calcium entry blocker that has potential therapeutic use as an antiasthmatic agent. Although displaying typical potent inhibition of 45Ca uptake into aortic rings (IC50 = 7.1 nM) and displacement of [3H]nitrendipine from cardiac membranes (IC50 = 137 nM), RWJ-22108 demonstrates tissue selectivity in the inhibition of KCl-induced contractions. RWJ-22108 inhibits the calcium-dependent contraction of canine bronchiolar smooth muscle with an IC50 of 5.7 nM. The IC50 femoral artery/IC50 bronchiolar ratios are 2.85, 8.02, 1.47 and 1.96 for nifedipine, RWJ-22108, verapamil, and gallopamil, respectively. Furthermore, this selectivity ratio (range 2.8-5.5) of RWJ-22108 is also observed when inhibition of other pulmonary and cardiovascular smooth muscles are compared. Using canine tracheal muscle and rabbit aortae, the IC50 aorta/IC50 trachea ratio is 1.75 for RWJ-22108 compared to approximately 0.5 for several calcium blocker standards. These results indicate that in vitro RWJ-22108 is a bronchoselective calcium channel blocker.

References

Chand N, Perhach Jr J, Diamantis W, Sofia R . Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review. Agents Actions. 1986; 17(5-6):407-17. DOI: 10.1007/BF01965507. View

Barnes P, Wilson N, Brown M . A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax. 1981; 36(10):726-30. PMC: 471744. DOI: 10.1136/thx.36.10.726. View

Ohtsuka M, Yokota M, Kodama I, Yamada K, Shibata S . New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype. Gen Pharmacol. 1989; 20(5):539-56. DOI: 10.1016/0306-3623(89)90084-0. View

Goodman F, Weiss G, Weinberg M, Pomarantz S . Effects of added or substituted potassium ion on 45 Ca movements in rabbit aortic smooth muscle. Circ Res. 1972; 31(5):672-81. DOI: 10.1161/01.res.31.5.672. View

Barnes P . Biochemistry of asthma. Trends Biochem Sci. 1991; 16(10):365-9. DOI: 10.1016/0968-0004(91)90152-l. View

Ritchie D, Kirchner T, Moore J, Dodd J, Ahmed T, Anderson D . Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker. Int Arch Allergy Immunol. 1993; 100(3):274-82. DOI: 10.1159/000236424. View

Yamamura H, Schoemaker H, Boles R, Roeske W . Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Commun. 1982; 108(2):640-6. DOI: 10.1016/0006-291x(82)90877-4. View

Henderson A, Costello J . The effect of nifedipine on bronchial reactivity to inhaled histamine and methacholine: a comparative study in normal and asthmatic subjects. Br J Dis Chest. 1988; 82(4):374-81. DOI: 10.1016/0007-0971(88)90091-5. View

Russi E, Marchette B, Yerger L, Abraham W, Ahmed T . Modification of allergic bronchoconstriction by a calcium antagonist: mode of action. Am Rev Respir Dis. 1983; 127(6):675-9. DOI: 10.1164/arrd.1983.127.6.675. View

10.

Triggle D . Calcium, the control of smooth muscle function and bronchial hyperreactivity. Allergy. 1983; 38(1):1-9. DOI: 10.1111/j.1398-9995.1983.tb00849.x. View

11.

Sperelakis N, Mras S . Depression of contractions of rabbit aorta and guinea pig vena cava by mesudipine and other slow channel blockers. Blood Vessels. 1983; 20(4):172-83. DOI: 10.1159/000158471. View

12.

Patakas D, Vlachoianni E, Tsara V, Louridas G, Argiropoulou P . Nifedipine in bronchial asthma. J Allergy Clin Immunol. 1983; 72(3):269-73. DOI: 10.1016/0091-6749(83)90031-3. View

13.

van Breemen C . Calcium requirement for activation of intact aortic smooth muscle. J Physiol. 1977; 272(2):317-29. PMC: 1353560. DOI: 10.1113/jphysiol.1977.sp012046. View

14.

Ozenne G, Moore N, Leprevost A, Tardif C, BOISMARE F, PASQUIS P . Nifedipine in chronic bronchial asthma: a randomized double-blind crossover trial against placebo. Eur J Respir Dis. 1985; 67(4):238-43. View

15.

GODFRAIND T, Miller R, Wibo M . Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986; 38(4):321-416. View

16.

Carpenter N, DBrot J, Kim C, Abraham W, Ahmed T . Effect of gallopamil, a calcium channel blocker, on carbachol- and histamine-induced bronchoconstriction in sheep. J Allergy Clin Immunol. 1988; 81(5 Pt 1):859-66. DOI: 10.1016/0091-6749(88)90943-8. View

17.

LOEV B, Goodman M, Snader M, Tedeschi R, MACKO E . "Hantzsch-type" dihydropyridine hypotensive agents. 3. J Med Chem. 1974; 17(9):956-65. DOI: 10.1021/jm00255a010. View

18.

Kendall H, Luscombe D . Calcium channel blocking drugs. Prog Med Chem. 1987; 24:249-97. DOI: 10.1016/s0079-6468(08)70424-7. View